The trademark YXgene was filed by SHENZHEN YUANXING GENE-TECH CO.,LTD, a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on August 16, 2023, and received one opposition filed on November 15, 2023 by Oxford Genetics Ltd on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by DEHNS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 15, 2023
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Vaccines
Pharmaceutical preparations for human use
Medicinal preparations and substances
Drugs for medical purposes
Pharmaceuticals
Chinese traditional medicinal herbs
Biochemical preparations for medical use
Blood components
Diagnostic preparations for medical purposes.
The mark was filed in class 42 with following description of goods:
Consultancy in the field of technological research
Consultancy in the field of biotechnology
Product development for others
Chemical analysis
Chemistry consultation
Biological research and analysis
Quality control
Scientific laboratory services
Clinical trials
Research and development services in the field of cytology.